Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) Short Interest Update

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKY) saw a significant increase in short interest in March. As of March 15th, there was short interest totalling 2,800 shares, an increase of 250.0% from the February 28th total of 800 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 531,600 shares, the days-to-cover ratio is currently 0.0 days.

Daiichi Sankyo Price Performance

DSNKY stock traded down $0.48 during trading on Thursday, hitting $24.57. 116,945 shares of the company’s stock traded hands, compared to its average volume of 245,706. The business has a fifty day simple moving average of $24.99 and a 200 day simple moving average of $29.02. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.11 and a current ratio of 2.77. Daiichi Sankyo has a 52 week low of $22.47 and a 52 week high of $42.48. The stock has a market capitalization of $46.89 billion and a price-to-earnings ratio of 28.57.

Daiichi Sankyo (OTCMKTS:DSNKY) last released its earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. As a group, research analysts expect that Daiichi Sankyo will post 0.73 EPS for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.